Education Sessions

Spring 2019

"Genetic Determinants of Late Effects in Childhood Cancer"

Monica Gramatges, MD, PhD

Texas Children's Hospital


"Social Determinants of Late Effects in Childhood Cancer Survivors"

Michael Scheurer, PhD, MPH

Texas Children's Hospital


"Passport for Care: Clinical and Research Applications."

Panel Discussion

Fall 2018

Pulmonary Toxicity

Lauren Faricy, MD

University of Vermont Medical Center

Second Cancers Risk Assessment and Screening

Spring 2018


"Treatment Associated Breast Cancer"

Lisa Diller, MD

Dana Farber Cancer Institute


"Treatment Associated Thyroid Cancer" Ari Wassner, MD

Boston Children's Hospital


"Hereditary Cancer Predisposition in Survivorship Care:

Junne Kamihara, MD, PhD

Dana Farber Cancer Institute/Boston Children's Hospital

Spring 2017

Cancer Genetics

"Inherited Cancer Syndromes and Implications for Survivorship Care" 

Tom Renaud, MD 

Rhode Island Hospital/Hasbro Children's Hospital


"Genetic Predisposition Syndromes in Pediatric Survivorship Clinic"

Lauren Massingham, MD 

Rhode Island Hospital/Hasbro Children's Hospital


"A Genetic Counselors Perspective on Genetics and Pediatric Oncology"

Jennifer Schwab MS CGC

Rhode Island Hospital/Hasbro Children's Hospital

Fall 2016

Psychologic Disorders

“Update on psychologic disorders in childhood cancer survivors: integrating psychologic care in survivorship programs”

Christopher Recklitis, PhD

Dana Farber Cancer Institute

Spring 2016

Healthy Lifestyles

"Male sexuality and intimacy across the life span in patients after cancer therapy" 

Stanton Honig, MD

Yale School of Medicine


"Interventions targeting obesity and physical activity in cancer survivors" Melinda Irwin, PhD, MPH

Yale School of Public Health


"Practical Aspects of Nutritional Recommendations for Young Adult Cancer Survivors"

Maura Harrigan, MS, RDN, CSO 

Yale School of Public Health


"The Benefits of Iintegrative Medicine"

Ather Ali, ND, MPH, MHS

Yale School of Medicine

Fall 2015

Neurotoxicity in Childhood Cancer Survivors

"Brief Overview of Neurotoxicity"

Nichole Ullrich, MD, PhD gave talk on behalf of Peter Manley, MD

DanaFarber Cancer Institute

"Peripheral Neuropathies"

Kristin Brown, Physical Therapy

Rhode Island Hospital/Hasbro Children's Hospital


"Treatment Associated Vasculopathies"

Nicole Ullrich, MD, PhD

Boston Children's Hospital/Dana Farber Cancer Institute

Fall 2014

Transition to Adult Care

“Got Transition: Overview of Transition from Pediatric to Adult care"

Niraj Sharma MD 

Boston Children's Hospital


“Transition the Pediatric Oncologists Perspective”

Lisa Kenney MD 

Boston Children's Hospital/Dana Farber Cancer Institute


“Implementing Transition Practices into Childhood Cancer Survivor Care” 

Group Discussion

Fall 2013

Renal Toxicity

Adam Weinstein, MD

Dartmouth-Hitchcock Medical Center


Avarum Traum, MD

Boston Children's Hospital

Spring 2013

Male Fertility

"Hypoandrogenism after Cancer Treatment"

Laurie Cohen, MD 

Boston Children's Hospital


"Infertility after Cancer Treatment"

Richard Yu, MD, PhD

Boston Children's Hospital


"Approaches to Fertility Preservation" 

Leena Nahata, MD 

Boston Children's Hospital


" Sexual Health "

Sharon Bober, PhD

Dana Farber Cancer Institue

Fall 2012

Bone Toxicity

"Overview of Bone Growth and Assessment of BMD"

Nina Ma, MD

Boston Children's Hospital


"Overview of Skeletal Toxicity in Childhood Cancer Survivors"

Lynda Vrooman, MD

Dana Farber Cancer Institute


"Endocrine Assessment and Interventions for Skeletal Toxicity"

Karen Loechner, MD



"Orthopedic complications and interventions"

Kevin Raskin, MD

Massachusetts General Hospital

Fall 2011

Female Fertility

“Risk factors for and prediction of ovarian failure in childhood cancer survivors”

Erin E. Barlow, MD

UMass Memorial Medical Center


“Fertility preservation for female childhood cancer survivors”

Sara Barton, MD

Brigham and Women's Hospital


“Costs and resources for fertility preservation” 

Elyse Levin-Russman, LCSW

MassGeneral Hospital for Children

Spring 2011

Second Cancers

"Chemotherapy Associated Second Cancers"

Howard Weinstein, MD

MassGeneral Hospital


"Radiation Associated Second Cancers"

Karen Marcus, MD

Dana Farber Cancer Institute


"Hereditary Cancer Predisposition"

David Sweetser, MD

MassGeneral Hospital


"Genetic Counseling/Testing for Cancer Predisposition"

Kathy Schneider, CGC

Dana Farber Cancer Institute

Neurocognitive Late Effects

"Neurocognitive Late Effects for Childhood Cancer Survivors"

Christine Trask, PhD

Rhode Island Hospital/Hasbro Children's Hospital


"Psychopharmacologic therapy for Neurocognative Late Effects"

Annah Abrams, MD

MassGeneral Hospital for Children

Fall 2010


Renee Margossian, MD 

Boston Children's Hospital


Virginia Beggs, NP 

Dartmouth-Hitchcock Medical Center 

Spring 2010

Endocrine Toxicity

Laurie Cohen, MD

Boston Children's Hospital



Kenney LB, Ames B, Michaud AL, Williams DN, Manley PE, Ulrich NJ. 

The management of childhood cancer survivors at risk for stroke: A Delphi survey of regional experts, Pediatr Blood Cancer. 2018.

Frederick N., Revette A, Campbell K, Moss K, Speckhart A, Kenney L, Mack J. Barriers and Facilitators to Sexual and Reproductive Health Communication between Pediatric Oncology Clinicians and Adolescent and Young Adult Patients: The Clinician Perspective. Pediatr Blood Cancer. 2018.

Welch JJG, Kenney LB, Hirway P, Usmani GN, Kadan-Lottick N, Grewal SS, Huang M, Bradeen H, Alder J, Diller L, Schwartz CL 

Understanding predictors of continued long-term pediatric cancer care across the region: a report from the Consortium for New England Childhood Cancer Survivors. Pediatr Blood Cancer. 2017.

Kenney LB, Bradeen H, Kadan-Lottick NS, Diller L, Homans A, Schwartz CL. 

The current status of follow-up services for childhood cancer survivors, are we meeting goals and expectations: A report from the consortium for New England childhood cancer survivors. Pediatr Blood Cancer. 2011.